Doximity (DOCS) EBITDA (2020 - 2026)

Doximity (DOCS) has 7 years of EBITDA data on file, last reported at $24.8 million in Q1 2026.

• Quarterly EBITDA fell 49.0% year-over-year to $24.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $214.9 million (down 5.65% YoY) and the FY2026 annual result came in at $214.9 million, down 5.65% from the prior year.
• EBITDA fell to $24.8 million in Q1 2026 per DOCS's latest filing, from $71.9 million in the prior quarter.
• Across five years, EBITDA topped out at $79.9 million in Q4 2024 and bottomed at $21.7 million in Q2 2022.
• The 5-year median for EBITDA is $41.9 million (2024), against an average of $44.7 million.
• The widest annual swing landed in 2024, when EBITDA surged 57.26%; it then tumbled 49.0% in 2026.
• Tracing DOCS's EBITDA over 5 years: stood at $38.5 million in 2022, then soared by 52.14% to $58.6 million in 2023, then jumped by 36.5% to $79.9 million in 2024, then dropped by 10.05% to $71.9 million in 2025, then slumped by 65.47% to $24.8 million in 2026.
• Per Business Quant, the three latest DOCS EBITDA figures stand at $24.8 million (Q1 2026), $71.9 million (Q4 2025), and $63.7 million (Q3 2025).

Peer Comparison